Literature DB >> 6832549

Alteration of fecal bacterial flora following oral administration of bifidobacterial preparation.

N Tamura, M Norimoto, K Yoshida, C Hirayama, R Nakai, A Takagi.   

Abstract

The fecal bacterial flora was examined in multiple stool specimens from 14 subjects with gastrointestinal disorders before, during and after the oral administration of bifidobacterial preparation (BBG, viable B. breve and B. bifidum, 3 X 10(9) or 6 X 10(9) per day) for 2 or 3 weeks. Enumerations of fecal bacterial flora showed no conspicuous alterations in total anaerobic bacterial counts during the BBG therapy, however the total number of bifidobacteria in feces increased significantly, and of E. coli and other aerobacteria showed a tendency to decline. The administered B. breve and B. bifidum were recovered in the feces at a concentration of 10(8)/g and of 10(7) to 10(8)/g, respectively. Both species continued to be excreted over 2 weeks after completion of the medication in the feces at concentrations of 10(6) to 10(7)/g and of 10(5) to 10(6)/g respectively, and diminished rapidly in 5 patients and continued at essentially the same level as during the medication in 6 patients. During the treatment the pH, urease activity and ammonia content in feces became lowered and showed a rerise after therapy. Symptomatic discomforts including abdominal distension and pain, anorexia, edema and fever of undetermined origin were reduced during the therapy. Urinalysis, hematological examinations and blood biochemical tests including blood ammonia level, however revealed no significant change.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832549     DOI: 10.1007/bf02774859

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  20 in total

1.  Beneficial effects of administration of Lactobacillus acidophilus in diarrheal and other intestinal disorders.

Authors:  C BECK; H NECHELES
Journal:  Am J Gastroenterol       Date:  1961-05       Impact factor: 10.864

2.  TREATMENT OF HEPATIC ENCEPHALOPATHY BY ALTERATION OF INTESTINAL FLORA WITH LACTOBACILLUS ACIDOPHILUS.

Authors:  W A MACBETH; E H KASS; W V MCDERMOTT
Journal:  Lancet       Date:  1965-02-20       Impact factor: 79.321

3.  [Postmortem examination of the intestinal flora of man].

Authors:  H HAENEL; W MULLER-BEUTHOW
Journal:  Zentralbl Bakteriol Orig       Date:  1958-07

4.  [Research on the antagonism between Bifidobacterium bifidum and aminogenic intestinal bacteria].

Authors:  A NEGISHI; C BILLY
Journal:  Ann Inst Pasteur (Paris)       Date:  1962-02

5.  [Possibilities of a physiological antibiotic therapy in the infant with Bacterium bifidum (Lactobacillus bifidus)].

Authors:  J B Mayer
Journal:  Monatsschr Kinderheilkd       Date:  1966-02

6.  [The faecal flora of man. II. The composition of bifidobacterium flora of different age groups (author's transl)].

Authors:  T Mitsuoka; K Hayakawa; N Kimura
Journal:  Zentralbl Bakteriol Orig A       Date:  1974-06

7.  Improved medium for selective isolation and enumeration of Bifidobacterium.

Authors:  R Tanaka; M Mutai
Journal:  Appl Environ Microbiol       Date:  1980-11       Impact factor: 4.792

8.  Effect of oral lactobacillus feedings on fecal lactobacillus counts.

Authors:  D Paul; L C Hoskins
Journal:  Am J Clin Nutr       Date:  1972-08       Impact factor: 7.045

9.  A direct colorimetric determination of blood ammonia.

Authors:  H Okuda; S Fujii; Y Kawashima
Journal:  Tokushima J Exp Med       Date:  1965-05

10.  [Microecological studies on the occurrence of germs of the Klebsiella-Aerobacter group in human feces].

Authors:  J Bendig; H Haenel
Journal:  Zentralbl Bakteriol Orig       Date:  1966-10
View more
  3 in total

1.  Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria.

Authors:  Y K Lee; C Y Lim; W L Teng; A C Ouwehand; E M Tuomola; S Salminen
Journal:  Appl Environ Microbiol       Date:  2000-09       Impact factor: 4.792

2.  Live and heat-inactivated lactobacilli from feces inhibit Salmonella typhi and Escherichia coli adherence to Caco-2 cells.

Authors:  S N Ostad; A A Salarian; M H Ghahramani; M R Fazeli; N Samadi; H Jamalifar
Journal:  Folia Microbiol (Praha)       Date:  2009-05-06       Impact factor: 2.099

3.  In vitro characterization of the adhesive factors of selected probiotics to Caco-2 epithelium cell line.

Authors:  Zhechko Dimitrov; Irina Gotova; Elena Chorbadjiyska
Journal:  Biotechnol Biotechnol Equip       Date:  2014-10-29       Impact factor: 1.632

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.